Immunotech Laboratories Enters Into Agreement To Market Potential Ebola Virus Disease (???EVD???) Treatment And Implement Strategy For Company’s ITV-1 Infectious Diseases Treatment In Africa
MONROVIA, Calif.–(BUSINESS WIRE)–Immunotech Laboratories, Inc. (OTC PINK: IMMB) (Immunotech or the Company) and wholly-owned subsidiary Immunotech Laboratories, BG (IMMB-BG) today announced that they have successfully completed negotiations with Uldic Investment Pvt. Ltd. (Uldic), located in Zimbabwe, to pursue the development of market opportunities related to the deadly Ebola virus, and to…
MabVax Therapeutics, Inc. Nominates The Fully Human Antibody HuMab 5B1 As The Company’s Lead Clinical Development Candidate
SAN DIEGO, Oct. 21, 2014 /PRNewswire/ — MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX) a clinical stage oncology drug development company, announced today that it has formally nominated its HuMab 5B1 antibody as a clinical candidate for the diagnosis and treatment of pancreatic and colon cancer. The fully…
SAN DIEGO, Oct. 21, 2014 /PRNewswire/ – Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced it will report financial results for the third quarter 2014 after closing of the NASDAQ Global Market on Tuesday, November 4, 2014.
A conference call hosted by William Welch, CEO, and other members of senior management will take place on Tuesday, November 4, 2014, at 5:00 p.m. EDT (2:00 p.m. PDT) and will be webcast live on the Sequenom Website.
To access the live teleconference call, dial 877-883-0383 in the U.S. and Canada, and 412-902-6506 for other international callers. Please use code 0747050. For interested parties unable to listen to the live conference call, a replay will be available through Friday, December 5, 2014. The replay will be accessible by dialing 877-344-7529 or 412-317-0088 international toll or Canada toll free at 855-669-9658, and entering the conference number 10054723.
The conference call webcast is also accessible through the “Invest” section of the Sequenom Website at www.sequenom.com/invest. An online replay will be available following the initial broadcast until Friday, December 5, 2014.
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving health care through revolutionary genomic and genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve molecular diagnostic markets. Web site: www.sequenom.com.
Logo – http://photos.prnewswire.com/prnh/20040415/SQNMLOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sequenom-inc-announces-date-of-third-quarter-2014-financial-results-and-conference-call-848332976.html
SOURCE Sequenom, Inc.
SAN DIEGO, CA–(Marketwired – Oct 21, 2014) – Ivera Medical Corporation is pleased to report that it successfully completed several days of an exhaustive and intensive review by the Food and Drug Administration (FDA) of Ivera’s manufacturing practices, quality control and regulatory filings. At the conclusion of the inspection, which was prompted by a complaint filed by a competitor (Catheter Connections), the inspector found that no corrective actions were needed. Ivera recently received a copy of the inspection report from the local FDA District Office confirming that the inspection is now considered officially closed.
This position is located in the company’s corporate office in San Diego ‘s biotech community. Software Design Engineer…. $78,000 – $100,000 a year
From The DP Store – 21 Oct 2014 07:48:41 GMT
– View all San Diego jobs
Chemist for a long-term temp assignment with a great biotech company in San Diego. The qualified candidate should be able to carry out analytical HPLC and GC method development independently under minimal supervision. Experience in…
5 years in the pharmaceutical/biotech industry/ GMP experience. Play an essential leadership role in the operation and troubleshooting of the mechanical plant…
From Roche – 21 Oct 2014 04:06:52 GMT
– View all Oceanside jobs
Knowledgeable of biotech industry and competitors. Excellent attention to detail. 12 months (extendable)….
From TalentBurst, Inc. – 21 Oct 2014 02:34:06 GMT
– View all Carlsbad jobs
Scripps Research-led team to study Lassa fever virus under a $6.6 million grant.
Excellent attention to detail. Maker, Excel experience preferred Knowledgeable of biotech industry and competitors…. $33.83 an hour
From The Norland Group – 21 Oct 2014 01:44:32 GMT
– View all Carlsbad jobs